Physician profile
Sara E Owen
NPI 1386664456
$5,145.38
in general payments reported to CMS, 2019-2025
45 companies · $792 in 2025
The $792 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,685 · 2020: $1,191 · 2021: $423 · 2022: $23.15 · 2023: $197 · 2024: $834 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,823.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $483.72 | 2019-2025 | Veozah |
| Novo Nordisk INC | $468.34 | 2019-2025 | Ozempic, Wegovy, Saxenda |
| Abbvie INC. | $458.25 | 2021-2025 | |
| Pfizer INC. | $430.21 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $424.31 | 2019-2025 | Farxiga, Breztri |
| Lilly USA, LLC | $368.37 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $345.54 | 2019-2025 | Otezla, Repatha, Repatha |
| Glaxosmithkline, LLC. | $260.78 | 2019-2024 | Trelegy Ellipta |
| Allergan, INC. | $179.82 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.02 | 2019-2025 | Ofev |
| Bayer Healthcare Pharmaceuticals INC. | $164.34 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $155.75 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $122.82 | 2024-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $120.41 | 2019-2025 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.82 | 2019-2024 | Xifaxan, Trulance |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Owen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.